🔔Stock Alerts via Telegram — Free for All Users

CHEK Stock Risk & Deep Value Analysis

CHEK

DVR Score

0.5

out of 10

Distressed

What You Need to Know About CHEK Stock

We analyzed CHEK using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran CHEK through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Extreme - Investment in CHEK as a standalone entity guarantees a complete loss of capital.. Here's what we found.

Updated Apr 15, 2026Run Fresh Analysis →

CHEK Risk Analysis & Red Flags

What Could Go Wrong

The company represented by the CHEK ticker fundamentally ceased to exist as an independent entity, making investment impossible. Any capital allocated to this ticker would result in a complete loss as it no longer represents an active, tradable company with independent operations.

Risk Matrix

Overall

Extreme - Investment in CHEK as a standalone entity guarantees a complete loss of capital.

Financial

N/A - Ticker is delisted.

Market

N/A - Ticker is delisted.

Competitive

N/A - Ticker is delisted.

Execution

N/A - Ticker is delisted.

Regulatory

N/A - Ticker is delisted.

Red Flags

  • Ticker CHEK is delisted from major exchanges.

  • Check-Cap Ltd. merged with Gataca Health Inc., now trading as GTCA.

  • No verifiable financial data exists for CHEK as a standalone entity.

  • The current price of $1.73 is likely a residual or ghost quote and does not represent an active trading company.

Upcoming Risk Events

  • 📅

    Complete capital loss due to the delisting and non-existence of CHEK as a tradable entity.

When to Reconsider

  • 🚪

    Any attempt to purchase shares under the CHEK ticker should be immediately reversed.

  • 🚪

    Confirmation of delisting and merger indicates zero intrinsic value for the CHEK ticker.

Unlock CHEK Risk Analysis & Red Flags

Create a free account to see the full analysis

Investment Thesis

Investment in CHEK as a standalone entity is impossible due to its delisting and merger into GTCA. The ticker no longer represents an active, tradable company, making any capital allocation a guaranteed loss.

Is CHEK Stock Undervalued?

Check-Cap Ltd. (CHEK) fundamentally ceased to exist as an independent growth vehicle following its merger with Gataca Health Inc. in March 2023. The combined entity now trades as GTCA, and the original CHEK ticker is delisted and no longer represents an active, tradable company with independent operations. The real-time market intelligence provided further corroborates this, showing 'no verifiable data' for Check-Cap Ltd. or any matching entity on requested metrics. Therefore, the likelihood of Check-Cap Ltd. achieving 10x growth as the specified entity is virtually zero due to its non-existence. Investing in CHEK as a standalone entity is impossible and would yield no return, classifying it as a complete dud. The score remains consistent with the previous assessment, as no material changes have occurred to alter its status.

Unlock the full AI analysis for CHEK

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

CHEK Price Targets & Strategy

000

Valuation Basis

The ticker CHEK is delisted and no longer represents an active, tradable company. Any investment would result in a complete loss of capital.

Entry Strategy

Not applicable; the ticker CHEK is delisted and not investable.

Exit Strategy

Not applicable; the ticker CHEK is delisted and not investable.

Portfolio Allocation

0% for any risk tolerance, as the entity is non-existent as a tradable stock.

Price Targets & Strategy

Upgrade to Premium for price targets and entry/exit strategies

Is CHEK Financially Healthy?

Profitability

Operating Margin

19.77%

Return on Equity

-55.41%

Revenue Growth

520000000000.00%

EPS

$-5.38

Balance Sheet

Current Ratio

0.15

Quick Ratio

0.15

Debt/Equity

0.33

Total Debt

$135.54M

Cash & Equivalents

$221.93M

Cash Flow

Operating Cash Flow

$5.20B

Free Cash Flow

$5.20B

EBITDA

$5.20B

Other

Beta (Volatility)

-0.07

Does CHEK Have a Competitive Moat?

Sign in to unlock

Moat Rating

⚪ None

Moat Trend

Eroding

The entity represented by the CHEK ticker no longer exists, so any historical moat has completely eroded.

Moat Erosion Risks

  • Complete dissolution of the independent entity.
  • Delisting from public exchanges.

CHEK Competitive Moat Analysis

Sign up to see competitive advantages

CHEK Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Not applicable; ticker is delisted and not actively discussed as a standalone investment.

Institutional Sentiment

Not applicable; ticker is delisted and not covered by analysts.

Insider Activity (Form 4)

Not applicable; ticker is delisted and no longer has active insider filings under CHEK.

Options Flow

Not applicable; no active options market for a delisted ticker. Normal options activity would be absent.

Earnings Intelligence

Next Earnings

Not applicable; ticker is delisted.

Surprise Probability

Not applicable; ticker is delisted.

Historical Earnings Pattern

Not applicable; ticker is delisted.

Key Metrics to Watch

Not applicable; ticker is delisted.

Competitive Position

Top Competitor

N/A

Market Share Trend

N/A - Ticker is delisted.

Valuation vs Peers

N/A - Ticker is delisted and has no peers for comparison.

Competitive Advantages

  • N/A - Ticker is delisted.

Market Intelligence

Get sentiment, earnings intel, and peer analysis with Premium

What Could Drive CHEK Stock Higher?

Near-Term (0-6 months)

  • Not applicable; ticker is delisted.

Medium-Term (6-18 months)

  • Not applicable; ticker is delisted.

Long-Term (18+ months)

  • Not applicable; ticker is delisted.

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for CHEK?

  • Any confirmation that the CHEK ticker represents a new, active, independent company (highly unlikely).

  • Verification of actual trading volume and verifiable financials under the CHEK ticker (currently absent).

Bull Case Analysis

See what could go right with Premium

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How CHEK Makes Money

The original Check-Cap Ltd., which previously focused on developing a disposable capsule system for colorectal cancer screening, ceased to exist as an independent entity after its merger with Gataca Health Inc. in March 2023. The combined entity now operates under the ticker GTCA. Therefore, the CHEK ticker no longer represents an active business model or revenue streams.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for CHEK (CHEK)?

As of April 15, 2026, CHEK has a DVR Score of 0.5 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of CHEK?

CHEK's market capitalization is approximately $13.1M..

What is the risk level for CHEK stock?

Our analysis rates CHEK's overall risk as Extreme - Investment in CHEK as a standalone entity guarantees a complete loss of capital.. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

Is CHEK's revenue growing?

CHEK has reported revenue growth of 520000000000.0%. The company is showing strong top-line momentum.

How often is the CHEK DVR analysis updated?

Our AI-powered analysis of CHEK is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 15, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for CHEK (CHEK) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to CHEK Stock Risk & Deep Value Analysis